Safe and tolerable one-hour pamidronate infusion for multiple myeloma patients

BACKGROUND: Once a month, patients with multiple myeloma received an infusion of bisphosphonates, principally to reduce osteoclastic bone resorption. Recommended infusion time for pamidronate is 2 hours in the US and 4 hours in Europe because of its potential nephrotoxicity. From 2003, a 90 mg infus...

Descripción completa

Detalles Bibliográficos
Autores principales: Chantzichristos, Dimitrios, Andréasson, Björn, Johansson, Peter
Formato: Texto
Lenguaje:English
Publicado: Dove Medical Press 2008
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2643118/
https://www.ncbi.nlm.nih.gov/pubmed/19337444

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2643118/
https://www.ncbi.nlm.nih.gov/pubmed/19337444

Ejemplares similares